Tempus AI (NASDAQ:TEM) Coverage Initiated at BTIG Research

Research analysts at BTIG Research assumed coverage on shares of Tempus AI (NASDAQ:TEM) in a report issued on Monday,Briefing.com Automated Import reports. The firm set a “buy” rating and a $60.00 price target on the stock. BTIG Research’s price objective points to a potential upside of 48.46% from the stock’s previous close.

A number of other research analysts also recently weighed in on the company. Guggenheim reissued a “buy” rating on shares of Tempus AI in a report on Tuesday, February 25th. Loop Capital decreased their target price on Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research report on Tuesday, January 14th. Bank of America boosted their target price on shares of Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a report on Monday, March 3rd. Needham & Company LLC reiterated a “buy” rating and set a $70.00 price objective on shares of Tempus AI in a research report on Thursday, April 10th. Finally, JPMorgan Chase & Co. lowered shares of Tempus AI from an “overweight” rating to a “neutral” rating and increased their price objective for the stock from $50.00 to $55.00 in a research report on Tuesday, February 25th. Six equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $61.08.

Tempus AI Stock Down 1.1 %

TEM stock opened at $40.42 on Monday. Tempus AI has a 52-week low of $22.89 and a 52-week high of $91.45. The firm has a 50 day moving average price of $53.49 and a 200-day moving average price of $50.52. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Insider Buying and Selling

In related news, CAO Ryan M. Bartolucci sold 13,770 shares of Tempus AI stock in a transaction on Friday, January 31st. The shares were sold at an average price of $60.00, for a total transaction of $826,200.00. Following the sale, the chief accounting officer now owns 57,237 shares of the company’s stock, valued at $3,434,220. The trade was a 19.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Erik Phelps sold 5,934 shares of the business’s stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $67.57, for a total value of $400,960.38. Following the completion of the sale, the executive vice president now owns 214,662 shares of the company’s stock, valued at $14,504,711.34. This trade represents a 2.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,146,249 shares of company stock valued at $301,185,058 over the last quarter.

Institutional Investors Weigh In On Tempus AI

Several hedge funds have recently bought and sold shares of the business. ARK Investment Management LLC boosted its holdings in Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock valued at $186,343,000 after purchasing an additional 3,141,487 shares during the period. Sumitomo Mitsui Trust Group Inc. increased its position in Tempus AI by 166.0% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after acquiring an additional 2,021,394 shares in the last quarter. Nikko Asset Management Americas Inc. boosted its position in Tempus AI by 166.0% in the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after buying an additional 2,021,394 shares during the last quarter. Franklin Resources Inc. grew its stake in Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock valued at $93,251,000 after purchasing an additional 1,950,862 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its position in Tempus AI by 86,947.2% during the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company’s stock worth $55,836,000 after purchasing an additional 1,651,996 shares during the period. 24.22% of the stock is owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.